Working… Menu
Trial record 23 of 178 for:    LENALIDOMIDE AND Leukemia

Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01553357
Recruitment Status : Completed
First Posted : March 14, 2012
Last Update Posted : March 14, 2012
Celgene Corporation
Information provided by (Responsible Party):
Pellegrino Musto, IRCCS Centro di Riferimento Oncologico della Basilicata

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2011
Actual Study Completion Date : September 2011